Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Revive Therapeutics Ltd. C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for rare disorders and infectious diseases. The Company is exploring the use of Bucillamine for the treatment of infectious diseases, with an initial focus on severe influenza and COVID-19. Through its subsidiary, Psilocin Pharma Corp., the Company is... see more

CSE:RVV - Post Discussion

Revive Therapeutics Ltd. > Blastoff is near
View:
Post by CrazyProphet on Feb 02, 2022 2:48pm

Blastoff is near

and so is FDA 3rd phase approval !!!
Comment by 1ottrunner on Feb 02, 2022 3:31pm
Judging from the number of shareholders willing to let go at this SP it seems most do not agree. FDA Approval, according to MF's timeline, wouldn't be before mid May. Consider this, if the trial was looking OH SO POSITIVE at dose selection, might they not have applied for EUA then? So, why didn't they?
Comment by Trippedstocks on Feb 02, 2022 3:45pm
the math says they needed more placebo participants. Depending on hospitalization rate of placebo and if buci was 0%, they needed about a minimum of 200 placebo for 80% blah blah blah... Alpha, blah blah. Etc. But at 400 analysis and dose selection they only had 133 placebo. Then to compare at 600 there would have been 233 placebo.
Comment by Hydroqc on Feb 02, 2022 11:13pm
The number of shares traded today in both Canada and USA, represent 0,14% of the total shares outstanding. When you say most, it could be a single one seller in each contry if you want to push conspiration. Could even be you, with the 250000 shares you bought recently, as you stated in a precedent post. You are not even funny. Just a phony day trader. The conclusions will be decided with the ...more  
Comment by 1ottrunner on Feb 03, 2022 5:25am
Hydro, I'm offering another opinion opposite of Cool888 and others that continually say this is about to hit $10. Those guys have been saying the same thing for 2 years, next week, next month, next quarter. To the moon. Any day now. Tell me you believe management isn't in over their head on this? Even the king of the hypesters, biomedical_trader, has commented that MF and his golf crew ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities